Tatyana Feldman, MD

home / authors / tatyana-feldman-md

Articles

Dr. Feldman on Adding Etoposide to Brentuximab Vedotin/CHP in Peripheral T-Cell Lymphomas

January 10th 2022

Tatyana Feldman, discusses the efficacy of adding etoposide to brentuximab vedotin followed by brentuximab vedotin consolidation in patients with newly diagnosed, CD30-expressing peripheral T-cell lymphomas.

Dr. Feldman on the Utility of PET Scan in Hodgkin Lymphoma

April 23rd 2020

Tatyana Feldman, MD, discusses the utility of PET Scan in Hodgkin Lymphoma.

Dr. Feldman on the Shortcomings of PET Scan in Hodgkin Lymphoma

March 26th 2020

Tatyana Feldman, MD, discusses the shortcomings of PET scan in Hodgkin lymphoma.

Dr. Feldman Discusses Using Doxil for CTCL

December 19th 2011

Dr. Tatyana Feldman, from the John Theurer Cancer Center, Discusses Using Doxil for CTCL

Dr. Feldman Discusses the Difficulties of Rare Lymphomas

December 10th 2011

Dr. Tatyana Feldman from John Theurer Cancer Center Discusses the Difficulties of Rare Lymphomas

Nivolumab Plus Relatlimab Demonstrates Consistent Benefit for Patients with Advanced Melanoma

Dr Rini on Sustained Survival Outcomes After Completion of Pembrolizumab and Axitinib in ccRCC

Dr Tolaney on Final OS Data From the TROPiCS-02 Trial in HR+/HER2- Breast Cancer

BL-B01D1 Demonstrates Antitumor Activity in EGFR+ NSCLC and Other Solid Tumors

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512